Review of synergistic anticancer effects of natural compounds combined with conventional therapeutics against chemoresistance and progression of pancreatic cancer

Woonghee Lee,Gwonhwa Song,Hyocheol Bae
DOI: https://doi.org/10.1007/s13273-024-00483-1
2024-11-27
Molecular & Cellular Toxicology
Abstract:According to cancer statistics from 2024, pancreatic ductal adenocarcinoma (PDAC), the most common type of pancreatic cancer, ranks third in terms of mortality worldwide and has one of the worst 5 year survival rates among all cancers. The heterogeneity of PDAC microenvironments contributes to chemotherapeutic resistance.
toxicology
What problem does this paper attempt to address?